It demonstrated that folic acid rescued cardiomyocytes from HGF-induced damage in a dose-dependent manner and decreased pyroptosis, the in vivo study also showed an decreased blood glucose levels, body weight and pyroptosis after folic acid treatment, indicating that folic acid supplementation is potentially beneficial for diabetes patients with cardiomyopathies. The gene discussed is HGF; the disease is diabetes mellitus.